bluebird bio, Inc. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for September 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20 2017 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Option Exercise | A | 133.05 | 10,700 | 1,423,635 | 10,700 | |
| Sep 20 2017 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Grant | A | 0.00 | 2,700 | 0 | 2,700 | 0 to 2.7 K |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 2.09 | 18,868 | 39,434 | 0 | |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 131.82 | 600 | 79,090 | 5,843 | 6.4 K to 5.8 K (-9.31 %) |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 131.19 | 18,268 | 2,396,643 | 6,443 | 24.7 K to 6.4 K (-73.93 %) |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 2.09 | 18,868 | 39,434 | 24,711 | 5.8 K to 24.7 K (+322.92 %) |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | M | 30.47 | 6,000 | 182,820 | 14,000 | |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 127.00 | 4,730 | 600,716 | 2,000 | 6.7 K to 2 K (-70.28 %) |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 126.15 | 1,270 | 160,207 | 6,730 | 8 K to 6.7 K (-15.87 %) |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Buy | M | 30.47 | 6,000 | 182,820 | 8,000 | 2 K to 8 K (+300.00 %) |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 4,900 | 26,952 | 67,485 | |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 126.43 | 1,418 | 179,280 | 27,305 | 28.7 K to 27.3 K (-4.94 %) |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 125.44 | 3,482 | 436,785 | 28,723 | 32.2 K to 28.7 K (-10.81 %) |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 4,900 | 26,952 | 32,205 | 27.3 K to 32.2 K (+17.95 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 25,750 | |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 126.60 | 700 | 88,620 | 29,484 | 30.2 K to 29.5 K (-2.32 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 125.82 | 1,550 | 195,015 | 30,184 | 31.7 K to 30.2 K (-4.88 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 31,734 | 30.5 K to 31.7 K (+4.10 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 12,000 | 66,005 | 91,151 | |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 130.01 | 9,000 | 1,170,112 | 15,977 | 25 K to 16 K (-36.03 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 126.60 | 700 | 88,620 | 24,977 | 25.7 K to 25 K (-2.73 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 126.16 | 2,300 | 290,173 | 25,677 | 28 K to 25.7 K (-8.22 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 12,000 | 66,005 | 27,977 | 16 K to 28 K (+75.11 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 12,000 | 66,005 | 72,385 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 125.01 | 12,000 | 1,500,091 | 27,305 | 39.3 K to 27.3 K (-30.53 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 12,000 | 66,005 | 39,305 | 27.3 K to 39.3 K (+43.95 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | M | 8.16 | 2,000 | 16,312 | 19,361 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Sell | S | 115.07 | 2,000 | 230,145 | 3,176 | 5.2 K to 3.2 K (-38.64 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Buy | M | 8.16 | 2,000 | 16,312 | 5,176 | 3.2 K to 5.2 K (+62.97 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 5.50 | 500 | 2,750 | 23,342 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 120.00 | 500 | 60,000 | 2,800 | 3.3 K to 2.8 K (-15.15 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 5.50 | 500 | 2,750 | 3,300 | 2.8 K to 3.3 K (+17.86 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | M | 5.50 | 6,364 | 35,005 | 243,355 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 130.04 | 22,500 | 2,925,983 | 273,232 | 295.7 K to 273.2 K (-7.61 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Buy | M | 5.50 | 6,364 | 35,005 | 295,732 | 289.4 K to 295.7 K (+2.20 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 115.09 | 24,333 | 2,800,461 | 289,368 | 313.7 K to 289.4 K (-7.76 %) |